Traws Pharma, Inc.
Current role
TRAW
Dr. Steven M. Fruchtman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Steven M. Fruchtman
Traws Pharma, Inc. reported in an 8-K filed April 4, 2024 that Dr. Steven M. Fruchtman resigned as Chief Executive Officer, effective April 1, 2024. Traws Pharma, Inc. reported in an 8-K filed April 4, 2024 that Dr. Steven M. Fruchtman resigned as Board, effective April 1, 2024.
“accepted the resignations of Dr. Steven M. Fruchtman and Mark Guerin from their roles of Chief Executive Officer ("CEO") of the Company and Chief Operating Officer ("COO") of the Company, respectively”
“accepted the resignations of Dr. Steven M. Fruchtman, Peter Atadja, Jerome Groopman, and Viren Mehta from the Board”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Traws Pharma, Inc. (TRAW)
SEC 8-K
Current2024-04-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Traws Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Iain D. Dukes CEO, Board Member
- Iain Dukes CEO, Board Member
- Werner Cautreels CEO, Board Member
- Jack E. Stover Chairman
- Jack Stover Chairman
- James J. Marino, JD, MBA Chairman
- Charles Parker CFO
- Nora Brennan CFO
- Nikolay Savchuk COO, Board Member
- Iain Dukes, D.Phil. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.